ISSN: 2472-1182
Signutra Inc, New Delhi, India
Dr. Chetan Mehndiratta is working as Head Medical Affairs at Signutra Inc, New Delhi, India. His Pharmacovigilance, Clinical Trials, Regulatory Affairs, Medicine, Healthcare. He has educated in the Royal College of Physicians, UK (PGPCN, Clinical Nutrition) and pursuing PGPCH (Pediatric), Eurpoean Academy of Pediatrics.
Research Article
"Effectiveness of Nutritional Supplement in Growth and Development of Children aged 2-12 years "
Author(s): Chetan Mehndiratta*, Jasjit Singh Bhasin, Vaman Khadilkar, IPS Kochar, Uday Pai, Guatam Mittal, Prashant Sanskar and Tanmay Agrawal
Objective: Post marketing study to determine the effect of 6 months consumption of nutritional supplement on growth and development of children aged 2-12 years.
Background: Young children in India suffer from some of the highest levels of stunting, underweight, and wasting observed in any country in the world. The levels of over-nutrition are also on a rise. Prevention of child malnutrition require diets providing adequate energy and essential nutrients to promote catch-up growth, strengthen resistance to infection, and support normal mental, physical and metabolic development.
Methods: This is an observational randomized controlled arm study, where anoral nutritional supplement is given to 776 children, aged 2-12 years, for 6 months along with normal diet. Anthropometric parameters (height, weight and BMI) are assesse.. View More»
DOI:
10.35248/2472-1182.21.6.126